236 related articles for article (PubMed ID: 32329414)
21. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
[TBL] [Abstract][Full Text] [Related]
23. High PKD2 predicts poor prognosis in lung adenocarcinoma via promoting Epithelial-mesenchymal Transition.
Pang Z; Wang Y; Ding N; Chen X; Yang Y; Wang G; Liu Q; Du J
Sci Rep; 2019 Feb; 9(1):1324. PubMed ID: 30718593
[TBL] [Abstract][Full Text] [Related]
24. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
Tu Z; Xie S; Xiong M; Liu Y; Yang X; Tembo KM; Huang J; Hu W; Huang X; Pan S; Liu P; Altaf E; Kang G; Xiong J; Zhang Q
Int J Oncol; 2017 Feb; 50(2):505-514. PubMed ID: 28000861
[TBL] [Abstract][Full Text] [Related]
25. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
26. Identification SYT13 as a novel biomarker in lung adenocarcinoma.
Zhang L; Fan B; Zheng Y; Lou Y; Cui Y; Wang K; Zhang T; Tan X
J Cell Biochem; 2020 Feb; 121(2):963-973. PubMed ID: 31625195
[TBL] [Abstract][Full Text] [Related]
27. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
[TBL] [Abstract][Full Text] [Related]
28. Protease-activated receptor 2 induces migration and promotes Slug-mediated epithelial-mesenchymal transition in lung adenocarcinoma cells.
Tsai CC; Chou YT; Fu HW
Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):486-503. PubMed ID: 30321617
[TBL] [Abstract][Full Text] [Related]
29. Loss of FGL1 induces epithelial‑mesenchymal transition and angiogenesis in LKB1 mutant lung adenocarcinoma.
Bie F; Wang G; Qu X; Wang Y; Huang C; Wang Y; Du J
Int J Oncol; 2019 Sep; 55(3):697-707. PubMed ID: 31322182
[TBL] [Abstract][Full Text] [Related]
30. LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma.
Hou XM; Yuan SQ; Zhao D; Liu XJ; Wu XA
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509961
[TBL] [Abstract][Full Text] [Related]
31. Association Between CD133 Expression and Prognosis in Human Lung Adenocarcinoma.
Yamashita N; Oyama T; So T; Miyata T; Yoshimatsu T; Nakano R; Matsunaga W; Gotoh A
Anticancer Res; 2021 Feb; 41(2):905-910. PubMed ID: 33517296
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of geranylgeranyl diphosphate synthase contributes to tumour metastasis and correlates with poor prognosis of lung adenocarcinoma.
Wang X; Xu W; Zhan P; Xu T; Jin J; Miu Y; Zhou Z; Zhu Q; Wan B; Xi G; Ye L; Liu Y; Gao J; Li H; Lv T; Song Y
J Cell Mol Med; 2018 Apr; 22(4):2177-2189. PubMed ID: 29377583
[TBL] [Abstract][Full Text] [Related]
33. miR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop.
Shi L; Wang Y; Lu Z; Zhang H; Zhuang N; Wang B; Song Z; Chen G; Huang C; Xu D; Zhang Y; Zhang W; Gao Y
Oncogene; 2017 Mar; 36(12):1631-1643. PubMed ID: 27869168
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma.
Zhou J; Xiao H; Yang X; Tian H; Xu Z; Zhong Y; Ma L; Zhang W; Qiao G; Liang J
Sci Rep; 2018 Jan; 8(1):37. PubMed ID: 29311567
[TBL] [Abstract][Full Text] [Related]
35. TFAP2A Induced KRT16 as an Oncogene in Lung Adenocarcinoma via EMT.
Yuanhua L; Pudong Q; Wei Z; Yuan W; Delin L; Yan Z; Geyu L; Bo S
Int J Biol Sci; 2019; 15(7):1419-1428. PubMed ID: 31337972
[No Abstract] [Full Text] [Related]
36. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
[TBL] [Abstract][Full Text] [Related]
37. LFG-500, a novel synthetic flavonoid, suppresses epithelial-mesenchymal transition in human lung adenocarcinoma cells by inhibiting NLRP3 in inflammatory microenvironment.
Yang D; Cao X; Wang F; Jiang H; Feng D; Guo H; Du L; Jin Y; Chen Y; Yin X; Li C
Cancer Lett; 2017 Aug; 400():137-148. PubMed ID: 28461245
[TBL] [Abstract][Full Text] [Related]
38. Association between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma.
Sowa T; Menju T; Sonobe M; Nakanishi T; Shikuma K; Imamura N; Motoyama H; Hijiya K; Aoyama A; Chen F; Sato T; Kobayashi M; Yoshizawa A; Haga H; Sozu T; Date H
Cancer Med; 2015 Dec; 4(12):1853-62. PubMed ID: 26471868
[TBL] [Abstract][Full Text] [Related]
39. LncRNA TTN-AS1 drives invasion and migration of lung adenocarcinoma cells via modulation of miR-4677-3p/ZEB1 axis.
Zhong Y; Wang J; Lv W; Xu J; Mei S; Shan A
J Cell Biochem; 2019 Oct; 120(10):17131-17141. PubMed ID: 31173403
[TBL] [Abstract][Full Text] [Related]
40. CCR9 Promotes Migration and Invasion of Lung Adenocarcinoma Cancer Stem Cells.
Lu L; Du H; Huang H; Wang C; Wang P; Zha Z; Wu Y; Liu X; Weng C; Fang X; Li B; Mao H; Wang L; Guan M; Liu G
Int J Med Sci; 2020; 17(7):912-920. PubMed ID: 32308544
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
